Honorio KM - Search Results

1

The Role of QSAR and Virtual Screening Studies in Type 2 Diabetes Drug Discovery.

Pantaleao SQ, Fujii DGV, Maltarollo VG, da C Silva D, Trossini GHG, Weber KC, Scott LPB, Honorio KM. Pantaleao SQ, et al. Among authors: honorio km. Med Chem. 2017;13(8):706-720. doi: 10.2174/1573406413666170522152102. Med Chem. 2017. PMID: 28530546 Review.

2

The use of classification methods for modeling the antioxidant activity of flavonoid compounds.

Weber KC, Honório KM, Bruni AT, da Silva AB. Weber KC, et al. Among authors: honorio km. J Mol Model. 2006 Sep;12(6):915-20. doi: 10.1007/s00894-005-0083-x. Epub 2006 Apr 7. J Mol Model. 2006. PMID: 16601967

3

Two-dimensional QSAR studies on arylpiperazines as high-affinity 5-HT(1A) receptor ligands.

Weber KC, Honório KM, Andricopulo AD, Da Silva AB. Weber KC, et al. Among authors: honorio km. Med Chem. 2008 Jul;4(4):328-35. doi: 10.2174/157340608784872325. Med Chem. 2008. PMID: 18673144

4

Theoretical study on the molecular and electronic properties of some substances used for diabetes mellitus treatment.

Maltarollo VG, Homem-de-Mello P, Honório KM. Maltarollo VG, et al. Among authors: honorio km. J Mol Model. 2010 Apr;16(4):799-804. doi: 10.1007/s00894-009-0627-6. Epub 2009 Dec 12. J Mol Model. 2010. PMID: 20012454

5

Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands.

Weber KC, Salum LB, Honório KM, Andricopulo AD, da Silva AB. Weber KC, et al. Among authors: honorio km. Eur J Med Chem. 2010 Apr;45(4):1508-14. doi: 10.1016/j.ejmech.2009.12.059. Epub 2010 Jan 13. Eur J Med Chem. 2010. PMID: 20133028

6

Insights into the molecular requirements for the anti-obesity activity of a series of CB1 ligands.

Weber KC, De Lima EF, De Mello PH, Da Silva AB, Honório KM. Weber KC, et al. Among authors: honorio km. Chem Biol Drug Des. 2010 Oct;76(4):320-9. doi: 10.1111/j.1747-0285.2010.01016.x. Epub 2010 Sep 2. Chem Biol Drug Des. 2010. PMID: 20887613

7

Role of physicochemical properties in the activation of peroxisome proliferator-activated receptor δ.

Maltarollo VG, Homem-de-Mello P, Honorio KM. Maltarollo VG, et al. Among authors: honorio km. J Mol Model. 2011 Oct;17(10):2549-58. doi: 10.1007/s00894-010-0935-x. Epub 2011 Jan 5. J Mol Model. 2011. PMID: 21207086

8

Ligand- and structure-based drug design strategies and PPARδ/α selectivity.

Maltarollo VG, Honório KM. Maltarollo VG, et al. Among authors: honorio km. Chem Biol Drug Des. 2012 Oct;80(4):533-44. doi: 10.1111/j.1747-0285.2012.01424.x. Epub 2012 Jul 12. Chem Biol Drug Des. 2012. PMID: 22672760

9

Molecular features for antitrypanosomal activity of thiosemicarbazones revealed by OPS-PLS QSAR studies.

Lozano NB, Maltarollo VG, Weber KC, Honorio KM, Guido RV, Andricopulo AD, Da Silva AB. Lozano NB, et al. Among authors: honorio km. Med Chem. 2012 Nov;8(6):1045-56. doi: 10.2174/1573406411208061045. Med Chem. 2012. PMID: 22779790

10

Machine learning techniques and drug design.

Gertrudes JC, Maltarollo VG, Silva RA, Oliveira PR, Honório KM, da Silva AB. Gertrudes JC, et al. Among authors: honorio km. Curr Med Chem. 2012;19(25):4289-97. doi: 10.2174/092986712802884259. Curr Med Chem. 2012. PMID: 22830342 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters